Guaifenesin/codeine is a fixed-dose combination cold medicine used for the treatment of cough.^[1] It contains guaifenesin, an expectorant; and codeine, as the phosphate, an opioid antitussive.^[1] It is taken by mouth.^[1]

It was approved for medical use in the United States in 2006.^[1] In 2021, it was the 297th most commonly prescribed medication in the United States, with more than 500,000 prescriptions.^[3][4]

Society and culture

Brand names

Guaifenesin/codeine is available under multiple brand names including Allfen CD, Antituss AC, Bitex, Bron-Tuss, Brontex, Cheracol with Codeine, Cheratussin, Cheratussin AC, Codafen, Codar GF, Coditussin AC, Dex-Tuss, Diabetic Tussin C, Duraganidin NR, ExeClear-C, G Tussin AC, Gani-Tuss NR, Glydeine, Guaiatussin AC, Guaiatussin AC Sugar Free, Guaifen AC, Guaifenesin AC, Guiatuss AC, Guiatussin with Codeine, Halotussin AC, Iophen, Iophen-C NR, M-Clear, M-Clear WC, Mar-cof CG, Maxi-Tuss AC, Mytussin AC, Relcof C, Robafen AC, Robichem AC, Robitussin AC, Romilar AC, Tussi Organidin, Tussiden C, Tusso-C, Virtussin A/C, and Virtussin AC.^[5][6][7][8]

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e